Agenus (AGEN)
(Delayed Data from NSDQ)
$16.97 USD
+1.28 (8.16%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $17.00 +0.03 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Price, Consensus and EPS Surprise
AGEN 16.97 +1.28(8.16%)
Will AGEN be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for AGEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AGEN
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates
AGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates
Milestone Pharma (MIST) Down on Regulatory Update for Etripamil
Other News for AGEN
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
Agenus: Multiple Milestones In The Second Half Of 2024
7 Biotech Stocks to Put on Your Breakthrough Radar
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Buy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study Results